A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101

NCT07403188 · clinicaltrials.gov ↗

RECRUITING

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Refractory Lupus Nephritis
Myasthaenia Gravis
Stiff Person Syndrome
Rheumatoid Arthritis (RA)
Multiple Sclerosis
Dermatomyositis
Systemic Sclerosis (SSc)

Interventions

DRUG: KYV-101

Sponsor

Kyverna Therapeutics